Pro Share Advisors LLC Vyne Therapeutics Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$0.91 - $1.5 $10,014 - $16,507
-11,005 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$1.39 - $3.47 $15,296 - $38,187
11,005 New
11,005 $15,000
Q2 2021

Aug 13, 2021
SELL
$3.24 - $6.92 $54,389 - $116,166
-16,787 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$6.34 - $12.68 $106,429 - $212,859
16,787 New
16,787 $115,000

Others Institutions Holding VYNE

# of Institutions
2
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $176M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email